01276 HENGRUI PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 8.08X | Oper Margin | 27.9% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 24.4% |
| Total Debt/Equity | 0.1% | Return on Equity | 12.6% |
| Price/Book | 6.48X | Return on Assets | 11.0% |
| (HKD 66.650) | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | 8,576.11 | 6,733.50 | 4,738.38 | 4,377.87 |
|---|---|---|---|---|
| Net Profit Growth (%) | +27.4 | +42.1 | +8.2 | N/A |
| Earnings Per Share (HKD) | 1.319 | 1.06 | 0.745 | 0.689 |
| Earnings Per Share Growth (%) | +24.4 | +42.3 | +8.1 | N/A |
| Dividend Per Share (HKD) | 0.223 | No dividend | No dividend | No dividend |
| P/E* (X) | 50.52 | 62.85 | 89.43 | 96.68 |
| Yield (%) | 0.33 | N/A | N/A | N/A |
| Dividend Share (%) | 16.87 | N/A | N/A | N/A |
| Book NAV (HKD) | 10.282 | N/A | N/A | N/A |
| Auditors' Opinion | Unqualified | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 31,629 | 27,985 | +13.0 | 22,820 |
| Operating Result | 8,804 | 7,191 | +22.4 | 4,740 |
| Associates | -97.143 | -21.581 | +350.1 | -72.696 |
| Profit Before Taxation | 8,708 | 7,170 | +21.5 | 4,667 |
| Taxation | 990.623 | 832.695 | +19.0 | 389.289 |
| Profit /( Loss) After Taxation | 7,717 | 6,337 | +21.8 | 4,278 |
| Minority Interests | 5.947 | 0.468 | +1,170.7 | -24.615 |
| Net Profit | 7,705 | 6,331 | +21.7 | 4,299 |
| Earnings Per Share () | 1.3194 | 1.0604 | +24.4 | 0.7453 |
| Dividend Per Share () | 0.2226 | N/A | N/A | N/A |
| Announcement Date | 2026-03-26 | 2025-05-15 | NA | 2025-05-15 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
